Aldeyra Therapeutics, Inc. (ALDX)

Aldeyra Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	50.35	54.53	142.82	144.42	104.79	52.86
Short-Term Investments	39.71	46.62	-	29.88	-	-
Cash & Short-Term Investments	90.06	101.15	142.82	174.3	104.79	52.86
Cash Growth	8.46%	-29.18%	-18.06%	66.33%	98.25%	16.52%
Other Receivables	0.76	-	-	3.24	0.03	-
Receivables	0.76	-	-	3.24	125.03	25
Prepaid Expenses	0.47	0.71	0.52	0.87	0.53	0.41
Other Current Assets	1.44	2.21	4.46	2.61	2.4	4.79
Total Current Assets	92.73	104.07	147.81	181.02	232.75	83.06
Property, Plant & Equipment	0.47	0.27	0.52	0.27	0.38	0.29
Long-Term Deferred Charges	-	0.27	-	-	-	-
Total Assets	93.2	104.61	148.33	181.29	233.14	83.35
Accounts Payable	0.35	0.18	1.34	0.13	1.02	0.38
Accrued Expenses	7.68	12.12	5.54	14.07	10.52	5.63
Current Portion of Long-Term Debt	-	0.03	15.15	0.91	-	3.66
Current Portion of Leases	0.26	0.27	0.24	0.25	0.23	0.23
Current Unearned Revenue	6	6	-	-	-	-
Other Current Liabilities	-	-	-	-	-	2.5
Total Current Liabilities	14.29	18.6	22.26	15.36	11.77	12.41
Long-Term Debt	15.1	15	-	14.92	15.5	11.43
Long-Term Leases	0.21	-	0.27	-	0.13	-
Long-Term Unearned Revenue	-	-	6	-	-	-
Total Liabilities	29.6	33.6	28.53	30.28	27.4	23.84
Common Stock	0.06	0.06	0.06	0.06	0.06	0.04
Additional Paid-In Capital	523.58	521.02	513.99	507.77	500.37	296.39
Retained Earnings	-460.04	-450.11	-394.26	-356.72	-294.69	-236.92
Comprehensive Income & Other	0	0.04	-	-0.1	-	-
Shareholders' Equity	63.6	71	119.8	151.01	205.74	59.51
Total Liabilities & Equity	93.2	104.61	148.33	181.29	233.14	83.35
Total Debt	15.57	15.3	15.66	16.08	15.86	15.33
Net Cash (Debt)	74.49	85.85	127.17	158.22	88.93	37.53
Net Cash Growth	10.55%	-32.49%	-19.63%	77.91%	136.96%	22.61%
Net Cash Per Share	1.25	1.44	2.16	2.71	1.65	1.10
Filing Date Shares Outstanding	59.9	59.71	58.9	58.58	58.1	47.25
Total Common Shares Outstanding	60.05	59.65	59.2	58.56	58.08	38.67
Working Capital	78.44	85.47	125.55	165.66	220.98	70.65
Book Value Per Share	1.06	1.19	2.02	2.58	3.54	1.54
Tangible Book Value	63.6	71	119.8	151.01	205.74	59.51
Tangible Book Value Per Share	1.06	1.19	2.02	2.58	3.54	1.54

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q